Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Sony
SONY
$133B
| $326K | ﹤0.01% |
15,880
-4,580
| -22% | -$99.5K |
|
3202
Flexsteel Industries
FLXS
$317M
| $324K | ﹤0.01% |
16,745
+6
| +0% | +$137 |
|
3203
SAP
SAP
$219B
| $322K | ﹤0.01% |
2,904
-209
| -7% | -$25.4K |
|
|
MBII
3204
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $322K | ﹤0.01% |
298,096
+85,771
| +40% | +$64.8K |
|
3205
Rallybio
RLYB
$84.6M
| $319K | ﹤0.01% |
5,698
+3,688
| +183% | +$305K |
|
3206
Park-Ohio Holdings
PKOH
$581M
| $316K | ﹤0.01% |
22,455
+806
| +4% | +$14.6K |
|
|
NAGE
3207
Niagen Bioscience
NAGE
$281M
| $314K | ﹤0.01% |
127,636
| – | – |
|
3208
NN Inc
NNBR
$279M
| $312K | ﹤0.01% |
108,200
| – | – |
|
|
CARM
3209
DELISTED
Carisma Therapeutics
CARM
| $311K | ﹤0.01% |
25,784
| – | – |
|
|
TBHC
3210
DELISTED
The Brand House Collective
TBHC
| $311K | ﹤0.01% |
33,468
-332
| -1% | -$4.73K |
|
|
AKUS
3211
DELISTED
Akouos Inc
AKUS
| $310K | ﹤0.01% |
65,113
| – | – |
|
3212
Velocity Financial
VEL
$692M
| $308K | ﹤0.01% |
28,119
+6,192
| +28% | +$76.3K |
|
|
PPTA
3213
Perpetua Resources
PPTA
$2.39B
| $305K | ﹤0.01% |
74,218
+3,877
| +6% | +$15.5K |
|
|
ORGN
3214
DELISTED
Origin Materials
ORGN
| $304K | ﹤0.01% |
1,536
| – | – |
|
3215
Escalade
ESCA
$294M
| $301K | ﹤0.01% |
22,769
-2,624
| -10% | -$37K |
|
3216
Cartesian Therapeutics
RNAC
$231M
| $296K | ﹤0.01% |
8,010
+353
| +5% | +$22.1K |
|
3217
Immuneering
IMRX
$270M
| $295K | ﹤0.01% |
45,441
+24,044
| +112% | +$231K |
|
3218
Arq
ARQ
$86.3M
| $295K | ﹤0.01% |
47,278
| – | – |
|
|
OLO
3219
DELISTED
Olo Inc
OLO
| $292K | ﹤0.01% |
21,971
| – | – |
|
|
SQZ
3220
DELISTED
SQZ Biotechnologies Company
SQZ
| $292K | ﹤0.01% |
60,693
+4,196
| +7% | +$26.6K |
|
|
CLPR
3221
Clipper Realty
CLPR
$44.4M
| $291K | ﹤0.01% |
32,002
-4,462
| -12% | -$41.7K |
|
|
ALPN
3222
DELISTED
Alpine Immune Sciences Inc
ALPN
| $291K | ﹤0.01% |
32,417
+2,294
| +8% | +$19.8K |
|
3223
Tonix Pharmaceuticals
TNXP
$170M
| $288K | ﹤0.01% |
2
| – | – |
|
3224
Fresenius Medical Care
FMS
$13.6B
| $287K | ﹤0.01% |
8,522
+276
| +3% | +$9.08K |
|
|
REFI
3225
Chicago Atlantic Real Estate Finance
REFI
$251M
| $287K | ﹤0.01% |
+16,134
| New | +$299K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.